• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶9在局灶性脑缺血后的作用:基因敲除及BB-94酶抑制的影响

Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

作者信息

Asahi M, Asahi K, Jung J C, del Zoppo G J, Fini M E, Lo E H

机构信息

Department of Neurology, Massachusetts General Hospital, and Harvard Medical School, Charlestown 02129, USA.

出版信息

J Cereb Blood Flow Metab. 2000 Dec;20(12):1681-9. doi: 10.1097/00004647-200012000-00007.

DOI:10.1097/00004647-200012000-00007
PMID:11129784
Abstract

It has been shown recently that matrix metalloproteinases (MMPs) are elevated after cerebral ischemia. In the current study, we investigated the pathophysiologic role for MMP-9 (gelatinase B, EC.3.4.24.35) in a mouse model of permanent focal cerebral ischemia, using a combination of genetic and pharmacologic approaches. Zymography and Western blot analysis demonstrated that MMP-9 protein levels were rapidly up-regulated in brain after ischemic onset. Reverse transcription polymerase chain reaction showed increased transcription of MMP-9. There were no differences in systemic hemodynamic parameters and gross cerebrovascular anatomy between wild type mice and mutant mice with a targeted knockout of the MMP-9 gene. After induction of focal ischemia, similar reductions in cerebral blood flow were obtained. In the MMP-9 knockout mice, ischemic lesion volumes were significantly reduced compared with wild type littermates in male and female mice. In normal wild type mice, the broad spectrum MMP inhibitor BB-94 (batimastat) also significantly reduced ischemic lesion size. However, BB-94 had no detectable protective effect when administered to MMP-9 knockout mice subjected to focal cerebral ischemia. These data demonstrate that MMP-9 plays a deleterious role in the development of brain injury after focal ischemia.

摘要

最近研究表明,脑缺血后基质金属蛋白酶(MMPs)水平会升高。在本研究中,我们采用基因和药理学相结合的方法,研究了MMP-9(明胶酶B,EC.3.4.24.35)在永久性局灶性脑缺血小鼠模型中的病理生理作用。酶谱分析和蛋白质印迹分析表明,缺血发作后大脑中MMP-9蛋白水平迅速上调。逆转录聚合酶链反应显示MMP-9转录增加。MMP-9基因靶向敲除的突变小鼠与野生型小鼠之间,全身血流动力学参数和大体脑血管解剖结构并无差异。局灶性缺血诱导后,二者脑血流量的减少情况相似。在雄性和雌性小鼠中,与野生型同窝小鼠相比,MMP-9基因敲除小鼠的缺血性损伤体积显著减小。在正常野生型小鼠中,广谱MMP抑制剂BB-94(batimastat)也能显著减小缺血性损伤大小。然而,给局灶性脑缺血的MMP-9基因敲除小鼠施用BB-94时,未检测到其具有保护作用。这些数据表明,MMP-9在局灶性缺血后脑损伤的发展中起有害作用。

相似文献

1
Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.基质金属蛋白酶9在局灶性脑缺血后的作用:基因敲除及BB-94酶抑制的影响
J Cereb Blood Flow Metab. 2000 Dec;20(12):1681-9. doi: 10.1097/00004647-200012000-00007.
2
Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.重组组织型纤溶酶原激活剂在短暂性局灶性脑缺血后通过基质金属蛋白酶-9 非依赖性途径诱导血脑屏障破裂。
Eur J Neurosci. 2011 Oct;34(7):1085-92. doi: 10.1111/j.1460-9568.2011.07843.x. Epub 2011 Sep 6.
3
Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse.基质金属蛋白酶抑制促进小鼠脑出血中的细胞死亡。
J Cereb Blood Flow Metab. 2008 Apr;28(4):752-63. doi: 10.1038/sj.jcbfm.9600572. Epub 2007 Oct 31.
4
Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia.金属蛋白酶组织抑制剂可保护局灶性脑缺血中的血脑屏障破坏。
J Cereb Blood Flow Metab. 2008 Oct;28(10):1674-85. doi: 10.1038/jcbfm.2008.59. Epub 2008 Jun 18.
5
PPARgamma agonist pioglitazone reduces matrix metalloproteinase-9 activity and neuronal damage after focal cerebral ischemia.过氧化物酶体增殖物激活受体γ激动剂吡格列酮可降低局灶性脑缺血后基质金属蛋白酶-9的活性并减轻神经元损伤。
Biochem Biophys Res Commun. 2009 Feb 27;380(1):17-21. doi: 10.1016/j.bbrc.2008.12.181. Epub 2009 Jan 9.
6
Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.脂蛋白受体介导的组织纤溶酶原激活物对基质金属蛋白酶的诱导作用。
Nat Med. 2003 Oct;9(10):1313-7. doi: 10.1038/nm926. Epub 2003 Sep 7.
7
Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke.缺血性中风后粒细胞集落刺激因子的内源性脑保护作用。
Exp Neurol. 2009 Jun;217(2):328-35. doi: 10.1016/j.expneurol.2009.03.018. Epub 2009 Mar 28.
8
Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.基质金属蛋白酶(MMP)抑制作用在小鼠胰腺癌模型中可选择性降低II型MMP活性。
J Surg Res. 1999 Jan;81(1):65-8. doi: 10.1006/jsre.1998.5447.
9
Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice.基质金属蛋白酶在大鼠和小鼠短暂性局灶性脑缺血后细胞凋亡中的作用
Eur J Neurosci. 2005 Oct;22(7):1597-608. doi: 10.1111/j.1460-9568.2005.04367.x.
10
Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia.基质金属蛋白酶在短暂性全脑缺血后迟发性神经元损伤中的作用
J Neurosci. 2004 Jan 21;24(3):671-8. doi: 10.1523/JNEUROSCI.4243-03.2004.

引用本文的文献

1
Unveiling the research directions for pyrrolidine-based small molecules as versatile antidiabetic and anticancer agents.揭示基于吡咯烷的小分子作为多功能抗糖尿病和抗癌药物的研究方向。
Future Med Chem. 2025 May;17(9):1039-1053. doi: 10.1080/17568919.2025.2501923. Epub 2025 May 12.
2
The Triad of Blood-Brain Barrier Integrity: Endothelial Cells, Astrocytes, and Pericytes in Perinatal Stroke Pathophysiology.血脑屏障完整性三联征:围产期卒中病理生理学中的内皮细胞、星形胶质细胞和周细胞
Int J Mol Sci. 2025 Feb 22;26(5):1886. doi: 10.3390/ijms26051886.
3
MMP-9 inhibitor SB-3CT improves neurological outcomes in ischemic stroke mice by modulation of astrocytic lipid metabolism.
基质金属蛋白酶-9抑制剂SB-3CT通过调节星形胶质细胞脂质代谢改善缺血性中风小鼠的神经功能结局。
Acta Pharmacol Sin. 2025 Mar 11. doi: 10.1038/s41401-025-01505-x.
4
The Role of Casr Inhibition-Mediated M2 Microglial Transformation in Ischemic Preconditioning Against Stroke.钙敏感受体抑制介导的M2小胶质细胞转化在缺血预处理抗脑卒中中的作用
Curr Med Sci. 2025 Feb;45(1):82-92. doi: 10.1007/s11596-025-00003-9. Epub 2025 Feb 21.
5
Role of Microglia in Stroke.小胶质细胞在中风中的作用。
Adv Neurobiol. 2024;37:405-422. doi: 10.1007/978-3-031-55529-9_23.
6
Elevated plasma matrix metalloproteinase 9 in schizophrenia patients associated with poor antipsychotic treatment response and white matter density deficits.精神分裂症患者血浆基质金属蛋白酶9升高与抗精神病药物治疗反应不佳及白质密度缺陷有关。
Schizophrenia (Heidelb). 2024 Aug 27;10(1):71. doi: 10.1038/s41537-024-00494-w.
7
Therapeutic Effects of Intranasal Administration of Resveratrol on the Rat Model of Brain Ischemia.白藜芦醇鼻腔给药对大鼠脑缺血模型的治疗作用
Heliyon. 2024 Jun 6;10(12):e32592. doi: 10.1016/j.heliyon.2024.e32592. eCollection 2024 Jun 30.
8
Insight into the pathophysiological advances and molecular mechanisms underlying cerebral stroke: current status.深入了解脑卒中风病理生理学进展和分子机制:现状。
Mol Biol Rep. 2024 May 11;51(1):649. doi: 10.1007/s11033-024-09597-0.
9
An Update of Kaempferol Protection against Brain Damage Induced by Ischemia-Reperfusion and by 3-Nitropropionic Acid.山奈酚对缺血再灌注和 3-硝基丙酸诱导的脑损伤的保护作用更新。
Molecules. 2024 Feb 8;29(4):776. doi: 10.3390/molecules29040776.
10
Oatp (Organic Anion Transporting Polypeptide)-Mediated Transport: A Mechanism for Atorvastatin Neuroprotection in Stroke.Oatp(有机阴离子转运多肽)介导的转运:阿托伐他汀治疗脑卒中神经保护的机制。
Stroke. 2023 Nov;54(11):2875-2885. doi: 10.1161/STROKEAHA.123.043649. Epub 2023 Sep 26.